Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-18

FDA Approved: FLUDEOXYGLUCOSE F-18 — Original Application (Pharmalogic South Carolina, LLC)

View source ↗

Summary

FDA approved Fludeoxyglucose F-18 as a radiopharmaceutical imaging agent for PET scans under an Original Application by Pharmalogic South Carolina, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

ORIG AP for FLUDEOXYGLUCOSE F-18 (FLUDEOXYGLUCOSE F-18)